References
- Stringaris A, Vidal-Ribas P, Brotman MA, et al. Practitioner Review: definition, recognition, and treatment challenges of irritability in young people. J Child Psychol Psychiatry. 2018;59:721–739.
- Leibenluft E, Cohen P, Gorrindo T, et al. Chronic versus episodic irritability in youth: a community-based, longitudinal study of clinical and diagnostic associations. J Child Adolesc Psychopharmacol. 2006;16:456–466.
- Waldman ID, Rowe R, Boylan K, et al. External validation of a bifactor model of oppositional defiant disorder. Mol Psychiatry. 2018 Dec 11. DOI:10.1038/s41380-018-0294-z.
- Masi G, Pisano S, Milone A, et al. Child behavior checklist dysregulation profile in children with disruptive behavior disorders: A longitudinal study. J Affect Disord. 2015;186:249–253.
- Evans SC, Burke JD, Roberts MC, et al. Irritability in child and adolescent psychopathology: an integrative review for ICD-11. Clin Psychol Rev. 2017;53:29–45.
- Kempes M, Matthys W, de Vries H, et al. Reactive and proactive aggression in children–a review of theory, findings and the relevance for child and adolescent psychiatry. Eur Child Adolesc Psychiatry. 2005;14:11–19.
- Wesselhoeft R, Stringaris A, Sibbersen C, et al. Dimensions and subtypes of oppositionality and their relation to comorbidity and psychosocial characteristics. Eur Child Adolesc Psychiatry. 2019;28:351–365.
- Eyberg SM, Nelson MM, Boggs SR. Evidence-based psychosocial treatments for children and adolescents with disruptive behavior. J Clin Child Adolesc Psychol. 2008;37:215–237.
- Bakker MJ, Greven CU, Buitelaar JK, et al. Practitioner review: psychological treatments for children and adolescents with conduct disorder problems - a systematic review and meta-analysis. J Child Psychol Psychiatry. 2017;58:4–18.
- Loy JH, Merry SN, Hetrick SE, et al. Atypical antipsychotics for disruptive behaviour disorders in children and youths. Cochrane Database Syst Rev. 2017;8:CD008559.
- Balia C, Carucci S, Coghill D, et al. The pharmacological treatment of aggression in children and adolescents with conduct disorder. Do callous-unemotional traits modulate the efficacy of medication? Neurosci Biobehav Rev. 2018;91:218–238.
- Gadow KD, Arnold LE, Molina BS, et al. Risperidone added to parent training and stimulant medication: effects on attention-deficit/hyperactivity disorder, oppositional defiant disorder, conduct disorder, and peer aggression. J Am Acad Child Adolesc Psychiatry. 2014;53:948–959.
- Connor DF, Glatt SJ, Lopez ID, et al. Psychopharmacology and aggression. I: A meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD. J Am Acad Child Adolesc Psychiatry. 2002;41:253–261.
- Pringsheim T, Hirsch L, Gardner D, et al. The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 1: psychostimulants, alpha-2 agonists, and atomoxetine. Can J Psychiatry. 2015;60:42–51.
- Pringsheim T, Hirsch L, Gardner D, et al. The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 2: antipsychotics and traditional mood stabilizers. Can J Psychiatry. 2015;60:52–61.